Medication info

Janusita Tablet 100 mg (Sitagliptin Phosphate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Phosphate›124.08mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Beige, round, biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Expired

MFDS item code 201503270 · Approved 2015.05.28

This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically after administration of this medicine. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used as monotherapy for initial treatment, and if blood sugar control is difficult with monotherapy, it may be used in combination with metformin. Additionally, if adequate control is not achieved with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be used additionally. When blood sugar control is difficult with other combination therapies, this medication may also be used to enhance treatment effectiveness. This medication helps improve blood sugar control at various treatment stages.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically after administration of this medicine. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication can cause severe allergic reactions, so if symptoms such as skin rash or difficulty breathing occur after taking the medication, it should be discontinued immediately and a doctor should be consulted. Also, acute pancreatitis, a serious inflammation of the pancreas, may occur, so if symptoms such as abdominal pain, vomiting, or nausea appear, medical personnel should be notified immediately. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis, nor should it be used in case of an allergy to this medication or its ingredients. Patients with decreased kidney function should adjust the dose of this medication, and it is important to regularly check kidney function before and during treatment. Hypoglycemic symptoms may occur while taking this medication, so caution is especially needed when used in combination with other hypoglycemic agents such as insulin or sulfonylureas, and the dose of those medications should be adjusted as necessary. Side effects such as headaches, upper respiratory infections, nasopharyngitis, diarrhea, nausea, abdominal pain, constipation, vomiting, myalgia, limb pain, back pain, pruritus, thrombocytopenia, dyspepsia, dizziness, increased blood triglycerides, increased low-density lipoprotein, hyperglycemia, weight loss, hypertension, hypernatremia, and erectile dysfunction may occur in some patients. Pregnant or breastfeeding women are advised not to take this medication, and safety and effectiveness have not been established for children under the age of 18. Elderly patients should be carefully evaluated for kidney function due to the potential for decreased kidney function, and regular kidney function testing is necessary. In case of overdose, general symptomatic treatment is provided, and some may be removed through dialysis, which should be considered if necessary. This medication has relatively few drug interactions, but caution is needed when used with digoxin or cyclosporine, and it is essential to consult with healthcare professionals regarding any other medications being taken. If severe joint pain or skin blistering occurs, the medication should be stopped immediately and a specialist should be consulted. The cardiovascular safety of this medication has been confirmed, but it is important to inform healthcare personnel of any unusual symptoms while taking this medication.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 26 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • elevated low-density lipoprotein
  • hyperglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This storage method will help maintain the medication's effectiveness and ensure safe use.

Appearance and packaging

Appearance

Beige, round, biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.